Sreoshi Chatterjee 452 posts 0 comments

Artificial intelligence imaging and workflow software, Viz.ai announced CE Mark of its Direct-to-intervention system, ContaCT that adopts to interpret brain CTs intimating a specialist…
Read More...

Clinical stage biopharmaceutical company, SAB Biotherapeutics declared its phase 1 Clinical Trial results for treating MERS, a study that was undertaken by National Institutes of…
Read More...